Metabolite Safety in Drug Development | Agenda Bookshop Skip to content
LAST CHANCE! Order items marked '10-20 working days' TODAY to get them in time for Christmas!
LAST CHANCE! Order items marked '10-20 working days' TODAY to get them in time for Christmas!
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Dennis A. Smith
B01=Suzanne L. Iverson
Category1=Non-Fiction
Category=TDCW
COP=United States
Delivery_Delivery within 10-20 working days
Language_English
PA=Available
Price_€100 and above
PS=Active
softlaunch

Metabolite Safety in Drug Development

English

A reference on drug metabolism and metabolite safety in the development phase, this book reviews the analytical techniques and experimental designs critical for metabolite studies. It features case studies of lessons learned and real world examples, along with regulatory perspectives from the US FDA and EMA.

    Reviews the analytical techniques and experimental designs critical for metabolite studies
    Covers methods including chirality, species differences, mass spectrometry, radiolabels, and in vitro / in vivo correlation
    Discusses target pharmacology, in vitro systems aligned to toxicity tests, and drug-drug interactions
    Includes perspectives from authors with firsthand involvement in industry and the study of drug metabolites, including viewpoints that have influenced regulatory guidelines See more
Current price €172.89
Original price €181.99
Save 5%
Age Group_Uncategorizedautomatic-updateB01=Dennis A. SmithB01=Suzanne L. IversonCategory1=Non-FictionCategory=TDCWCOP=United StatesDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=AvailablePrice_€100 and abovePS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Weight: 612g
  • Dimensions: 158 x 234mm
  • Publication Date: 23 Sep 2016
  • Publisher: John Wiley & Sons Inc
  • Publication City/Country: United States
  • Language: English
  • ISBN13: 9781118949658

About

Suzanne L. Iverson PhD ERT earned her PhD studying reactive drug metabolites and idiosyncratic drug reactions (University of Toronto Dr. Jack Uetrecht supervisor) and has worked in the pharmaceutical industry for over 14 years as principal scientist and manager of development in vitro/in vivo metabolism and distribution imaging as well as functional project leader for both DMPK and safety assessment functions. Since 2011 she has served on the management committee of the Drug Metabolism Discussion Group UK and the Board of the PKMetabolism subcommittee of the Swedish Pharmaceutical Society. Dennis A. Smith PhD currently holds part-time advisory and academic positions and previously worked in the pharmaceutical industry for 32 years. He has coauthored over 150 publications including Attrition in the Pharmaceutical Industry (Wiley 2016) Reactive Drug Metabolites (Wiley 2012) and three editions of the book Pharmacokinetics and Metabolism in Drug Design (Wiley 2012).

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept